PharmaVoice 100: Page 6
-
Profile // PharmaVoice 100
Legacy Leaders: Dr. Steven Steinhubl
The chief medical officer at physIQ is working at the intersection of healthcare, clinical trials and technology to deliver better, faster and more accurate treatments to patients around the globe.
By Karissa Waddick • Sept. 6, 2022 -
Profile // PharmaVoice 100
Disrupters: Dr. Tania Small
GSK’s medical oncology head is paving the way for patient-driven drug development and more equitable care.
By PharmaVoice staff • Sept. 6, 2022 -
Profile // PharmaVoice 100
Disrupters: Trishna Bharadia
As a patient advocate, The Spark Global’s owner is transforming how pharma companies approach patient centricity.
By Alexandra Pecci • Sept. 6, 2022 -
Profile // PharmaVoice 100
Entrepreneurs: Vincent Keunen
With his unique platform, the has built a bridge between patients, physicians and researchers around the world.
By Meagan Parrish • Sept. 6, 2022 -
Profile // PharmaVoice 100
Entrepreneurs: WeiQing Zhou
The COO has launched two jewels in the biotech world that complement each other while serving broader innovation goals throughout the industry.
By Meagan Parrish • Sept. 6, 2022 -
Profile // PharmaVoice 100
Disrupters: Dr. Yvonne Greenstreet
The CEO of Alnylam — a leader in RNAi therapies — has the company at the top of its game scientifically and culturally.
By PharmaVoice staff • Sept. 6, 2022 -
Tracker // PharmaVoice 100
The 2022 PharmaVoice 100
From standout executives to R&D pioneers — this year’s class of honorees is defining the next era of leadership.
By PharmaVoice staff • Sept. 6, 2022 -
PharmaVoice 100
The story behind the PharmaVoice 100
Taren Grom, our founding editor and the feature’s originator, explains how the coveted PharmaVoice 100 awards got its start and what makes it stand out in the industry.
By Meagan Parrish • Aug. 23, 2022 -
Podcast
Woman of the Week: Takeda Oncology’s Teresa Bitetti
Upon joining Takeda Pharmaceuticals as president of the global oncology unit, Teresa Bitetti had two important goals: to transform the business and create greater synergies between commercial and R&D operations.
By Taren Grom • Aug. 17, 2022 -
Making Moves
Making moves: Agios, BeiGene, Biocom California and more announce new key hires
The latest executive personnel changes from around the industry.
By Karissa Waddick • July 18, 2022 -
Podcast
Woman of the Week: OcuTerra Therapeutics' Kerrie Brady
The serial entrepreneur and now head of OcuTerra explains why taking risks in pharma pays off.
By Taren Grom • June 1, 2022 -
Sophia Sharp-Donaldson, executive director, Global Strategic Sourcing and Procurement, Kite Pharma and one of this year's HBA Luminary honorees.
OpinionWhy 'soft' skills matter in the new era of leadership
Standout leaders honored by the Healthcare Businesswomen's Association discuss the rising value of the interpersonal approach.
By Taren Grom • May 12, 2022 -
Podcast
Woman of the Week: AiCure's Michelle Marlborough
As chief product officer at AiCure, Michelle Marlborough is focused on solving tough patient challenges through technology.
By Taren Grom • May 11, 2022 -
Q&A // Biotech Spotlight
Sangamo has its finger on the next evolution of gene editing
Sangamo Therapeutics' CEO Sandy Macrae is bullish on his company’s ability to transform the genomic medicine arena.
By Taren Grom • March 31, 2022 -
Podcast
Woman of the Week: Daré Bioscience's Sabrina Martucci Johnson
The CEO is setting a path to transform women’s health at an opportune time.
By Taren Grom • March 30, 2022 -
Podcast
Woman of the Week: Genentech's Quita Highsmith
Quita Highsmith is changing how Genentech approaches diversity and inclusion across the board — from drug development to career advancement.
By Taren Grom • March 9, 2022 -
Q&A
Ramona Sequeira breaks PhRMA's glass ceiling
A few weeks ago, PhRMA, the industry’s largest trade group, announced that Sequeira has officially become chair of the organization’s board of directors. She is the first woman — and first woman of color — to take on the job.
By Taren Grom • March 7, 2022 -
Podcast
Woman of the Week: Lyndra Therapeutics' CEO Dr. Trish Hurter
With Lyndra's ultra-long-acting therapies, Hurter and the company are aiming to reinvent medicines.
By Taren Grom • March 2, 2022 -
The 2022 PharmaVoice 100 — new look, same drive for excellence
Some of the industry’s biggest names have been on our list of honorees. Now it’s time to find this year’s inspiring leaders.
By Taren Grom • Feb. 28, 2022 -
Q&A
Candel's CEO looks to help ignite a new era of cancer treatments
Candel Therapeutics is advancing a next-gen approach in oncology: using viruses to kill cancer cells at the site of injection.
By Taren Grom • Feb. 28, 2022 -
Profile
Guadalupe Hayes-Mota's 'recipe' for tackling pharma's supply chain issues
A quest to expand access to medical treatment globally led to a new career path when Guadalupe Hayes-Mota left his biotech leadership roles to start his own company.
By Robin Robinson • Feb. 25, 2022 -
Podcast
Woman of the Week: Sumitovant's Chief Business Development and Commercial Officer Adele Gulfo
Adele Gulfo, chief business development and commercial officer at Sumitovant Biopharma, is leaning into her decades of experience to bring a future-focused approach to drug development.
By Taren Grom • Feb. 23, 2022 -
Q&A
Saniona's CEO on why it takes a village to develop treatments for a rare disease
Saniona built its village by first hiring a head of patient advocacy.
By Kim Ribbink • Feb. 8, 2022 -
Ferring Pharmaceuticals president discusses the need for more funding in women's health research
Read why women's healthcare funding is such a challenge.
By Robin Robinson • Feb. 4, 2022 -
Retrieved from Google image.Opinion
Industry executives predict the next 'blue oceans' in pharma
Where life science leaders see breakthroughs happening in the industry.
By Taren Grom • Feb. 4, 2022